BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dogaru G, Bulboaca AE, Gheban D, Boarescu PM, Rus V, Festila D, Sitar-Taut AV, Stanescu I. Effect of Liposomal Curcumin on Acetaminophen Hepatotoxicity by Down-regulation of Oxidative Stress and Matrix Metalloproteinases. In Vivo 2020;34:569-82. [PMID: 32111755 DOI: 10.21873/invivo.11809] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Bulboacă AE, Porfire AS, Rus V, Nicula CA, Bulboacă CA, Bolboacă SD. Protective Effect of Liposomal Epigallocatechin-Gallate in Experimental Gentamicin-Induced Hepatotoxicity. Antioxidants 2022;11:412. [DOI: 10.3390/antiox11020412] [Reference Citation Analysis]
2 El-Hadary A, Sitohy M. Safely effective hypoglycemic action of stevia and turmeric extracts on diabetic Albino rats. J Food Biochem 2021;45:e13549. [PMID: 33161596 DOI: 10.1111/jfbc.13549] [Reference Citation Analysis]
3 Dziegielewska-Gesiak S. Metabolic Syndrome in an Aging Society - Role of Oxidant-Antioxidant Imbalance and Inflammation Markers in Disentangling Atherosclerosis. Clin Interv Aging 2021;16:1057-70. [PMID: 34135578 DOI: 10.2147/CIA.S306982] [Reference Citation Analysis]
4 Ashrafizadeh M, Zarrabi A, Hushmandi K, Zarrin V, Moghadam ER, Hashemi F, Makvandi P, Samarghandian S, Khan H, Hashemi F, Najafi M, Mirzaei H. Toward Regulatory Effects of Curcumin on Transforming Growth Factor-Beta Across Different Diseases: A Review. Front Pharmacol 2020;11:585413. [PMID: 33381035 DOI: 10.3389/fphar.2020.585413] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
5 Boarescu I, Boarescu P, Pop RM, Bocșan IC, Gheban D, Râjnoveanu R, Râjnoveanu A, Bulboacă AE, Buzoianu AD, Bolboacă SD. Curcumin Nanoparticles Enhance Antioxidant Efficacy of Diclofenac Sodium in Experimental Acute Inflammation. Biomedicines 2022;10:61. [DOI: 10.3390/biomedicines10010061] [Reference Citation Analysis]
6 Abou Assi R, Abdulbaqi IM, Siok Yee C. The Evaluation of Drug Delivery Nanocarrier Development and Pharmacological Briefing for Metabolic-Associated Fatty Liver Disease (MAFLD): An Update. Pharmaceuticals (Basel) 2021;14:215. [PMID: 33806527 DOI: 10.3390/ph14030215] [Reference Citation Analysis]